S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Baxter International Stock Forecast, Price & News

-0.01 (-0.01 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $80.04
50-Day Range
MA: $79.43
52-Week Range
Now: $80.04
Volume1.65 million shs
Average Volume2.69 million shs
Market Capitalization$40.89 billion
P/E Ratio45.48
Dividend Yield1.22%
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Baxter International logo


Overall MarketRank

2.29 out of 5 stars

Medical Sector

16th out of 1,556 stocks

Surgical & Medical Instruments Industry

1st out of 137 stocks

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment



Sales & Book Value

Annual Sales$11.36 billion
Cash Flow$4.83 per share
Book Value$15.50 per share


Net Income$1.00 billion


Market Cap$40.89 billion
Next Earnings Date2/4/2021 (Confirmed)
-0.01 (-0.01 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Baxter International (NYSE:BAX) Frequently Asked Questions

How has Baxter International's stock price been impacted by Coronavirus (COVID-19)?

Baxter International's stock was trading at $77.97 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BAX shares have increased by 2.7% and is now trading at $80.04.
View which stocks have been most impacted by COVID-19

Is Baxter International a buy right now?

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 6 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Baxter International stock.
View analyst ratings for Baxter International
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Baxter International?

Wall Street analysts have given Baxter International a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Baxter International wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Baxter International

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) issued its earnings results on Thursday, October, 29th. The medical instruments supplier reported $0.83 EPS for the quarter, topping the Zacks' consensus estimate of $0.73 by $0.10. The medical instruments supplier earned $2.97 billion during the quarter, compared to analyst estimates of $2.84 billion. Baxter International had a return on equity of 20.81% and a net margin of 7.90%. The company's revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period last year, the business posted $0.74 EPS.
View Baxter International's earnings history

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Monday, November 16th. Investors of record on Friday, December 4th will be given a dividend of $0.245 per share on Monday, January 4th. This represents a $0.98 annualized dividend and a yield of 1.22%. The ex-dividend date is Thursday, December 3rd.
View Baxter International's dividend history

Is Baxter International a good dividend stock?

Baxter International pays an annual dividend of $0.98 per share and currently has a dividend yield of 1.22%. Baxter International has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 29.61%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 28.49% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International's dividend history.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International updated its FY 2020 IntraDay earnings guidance on Monday, January, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $11.673-11.673 billion, compared to the consensus revenue estimate of $11.54 billion.

What price target have analysts set for BAX?

17 equities research analysts have issued twelve-month price objectives for Baxter International's shares. Their forecasts range from $84.00 to $105.00. On average, they expect Baxter International's stock price to reach $94.00 in the next twelve months. This suggests a possible upside of 17.4% from the stock's current price.
View analysts' price targets for Baxter International
or view Wall Street analyst' top-rated stocks.

Are investors shorting Baxter International?

Baxter International saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 6,670,000 shares, an increase of 29.0% from the December 15th total of 5,170,000 shares. Based on an average trading volume of 3,170,000 shares, the days-to-cover ratio is presently 2.1 days. Approximately 1.3% of the shares of the company are sold short.
View Baxter International's Short Interest

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), The Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

Who are Baxter International's key executives?

Baxter International's management team includes the following people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 58, Pay $2.12M)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 47, Pay $835.03k)
  • Mr. Sean B. W. Martin, Sr. VP & Gen. Counsel (Age 57, Pay $1.33M)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas and Global Bus. Units (Age 49, Pay $1.52M)
  • Mr. Cristiano Franzi, Sr. VP & Pres for EMEA (Age 57, Pay $1.5M)
  • Mr. Brian C. Stevens, Sr. VP, Chief Accounting Officer & Controller (Age 45)
  • Dr. Sumant Ramachandra, Pres of Pharmaceuticals and Sr. VP, Chief Science & Technology Officer (Age 51)
  • Mr. Talvis P. Love, Sr. VP & Chief Information Officer
  • Ms. Clare Trachtman, VP of Investor Relations
  • Ms. Jeanne K. Mason, Sr. VP of HR (Age 64)

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different retail and institutional investors. Top institutional investors include Huntington National Bank (0.11%), Jacobs & Co. CA (0.01%), Trust Co. of Toledo NA OH (0.01%), City Holding Co. (0.00%), Dalton Greiner Hartman Maher & Co. (0.00%) and Raymond James Trust N.A. (0.00%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Sean Martin, Third Point Llc and Thomas T Stallkamp.
View institutional ownership trends for Baxter International

Which institutional investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., NuWave Investment Management LLC, Huntington National Bank, City Holding Co., M&R Capital Management Inc., and Livingston Group Asset Management CO operating as Southport Capital Management. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, and John D Forsyth.
View insider buying and selling activity for Baxter International
or view top insider-selling stocks.

Which institutional investors are buying Baxter International stock?

BAX stock was acquired by a variety of institutional investors in the last quarter, including Jacobs & Co. CA, Park National Corp OH, Raymond James Trust N.A., BTR Capital Management Inc., Stillwater Investment Management LLC, and Trust Co. of Toledo NA OH.
View insider buying and selling activity for Baxter International
or or view top insider-buying stocks.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $80.04.

How big of a company is Baxter International?

Baxter International has a market capitalization of $40.89 billion and generates $11.36 billion in revenue each year. The medical instruments supplier earns $1.00 billion in net income (profit) each year or $3.31 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.

What is Baxter International's official website?

The official website for Baxter International is www.baxter.com.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.